AFP and hepatocellular carcinoma: The study’s objectives were to assess PIVKA-II’s sensitivity and specificity for the identification of HCC during surveillance, either by itself or in conjunction with AFP, and to ascertain whether PIVKA-II posed a meaningful risk factor for patient survival.